CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Viemed Healthcare - VMD CFD

    8.00
    0.12%
    0.07
    Low: 7.86
    High: 8.14
    Market Trading Hours* (UTC) Opens on Monday at 14:30

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Viemed Healthcare Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 8.01
    Open* 7.86
    1-Year Change* 11.81%
    Day's Range* 7.86 - 8.14
    52 wk Range 8.14-16.25
    Average Volume (10 days) 36.47K
    Average Volume (3 months) 471.25K
    Market Cap 411.21M
    P/E Ratio 42.85
    Shares Outstanding 38.28M
    Revenue 213.90M
    EPS 0.25
    Dividend (Yield %) N/A
    Beta 1.20
    Next Earnings Date Feb 29, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 8.00 0.14 1.78% 7.86 8.17 7.86
    Dec 7, 2023 8.01 -0.41 -4.87% 8.42 8.60 7.87
    Dec 6, 2023 8.37 0.39 4.89% 7.98 8.39 7.88
    Dec 5, 2023 7.93 0.28 3.66% 7.65 7.98 7.58
    Dec 4, 2023 7.74 0.09 1.18% 7.65 7.83 7.48
    Dec 1, 2023 7.63 0.04 0.53% 7.59 7.69 7.50
    Nov 30, 2023 7.73 -0.33 -4.09% 8.06 8.06 7.67
    Nov 29, 2023 8.03 -0.17 -2.07% 8.20 8.41 7.98
    Nov 28, 2023 8.21 0.27 3.40% 7.94 8.27 7.84
    Nov 27, 2023 8.01 0.28 3.62% 7.73 8.04 7.73
    Nov 24, 2023 7.92 0.12 1.54% 7.80 7.98 7.74
    Nov 22, 2023 7.78 -0.02 -0.26% 7.80 7.88 7.66
    Nov 21, 2023 7.80 0.16 2.09% 7.64 7.89 7.58
    Nov 20, 2023 7.67 0.02 0.26% 7.65 7.71 7.43
    Nov 17, 2023 7.66 0.18 2.41% 7.48 7.85 7.42
    Nov 16, 2023 7.34 0.19 2.66% 7.15 7.36 7.07
    Nov 15, 2023 7.22 -0.19 -2.56% 7.41 7.54 7.15
    Nov 14, 2023 7.34 0.30 4.26% 7.04 7.34 6.98
    Nov 13, 2023 7.04 0.14 2.03% 6.90 7.09 6.90
    Nov 10, 2023 7.09 0.28 4.11% 6.81 7.13 6.81

    Viemed Healthcare Events

    Time (UTC) Country Event
    Thursday, February 29, 2024

    Time (UTC)

    21:00

    Country

    CA

    Event

    Q4 2023 Viemed Healthcare Inc Earnings Release
    Q4 2023 Viemed Healthcare Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 138.832 117.062 131.309 80.256 64.464
    Revenue 138.832 117.062 131.309 80.256 64.464
    Cost of Revenue, Total 54.152 43.652 51.198 24.25 16.689
    Gross Profit 84.68 73.41 80.111 56.006 47.775
    Total Operating Expense 130.58 105.482 104.528 71.146 54.613
    Selling/General/Admin. Expenses, Total 73.363 60.043 57.711 45.267 37.006
    Depreciation / Amortization 1.012 0.851 0.816 0.671 0.588
    Interest Expense (Income) - Net Operating -0.363 0.205
    Unusual Expense (Income) 0.346 0.448 -2.328 0.36 0.054
    Operating Income 8.252 11.58 26.781 9.11 9.851
    Interest Income (Expense), Net Non-Operating 0.738 0.923 -0.418 -0.314 -0.181
    Net Income Before Taxes 8.99 12.503 26.363 8.796 9.67
    Net Income After Taxes 6.222 9.126 31.53 8.525 9.508
    Net Income Before Extra. Items 6.222 9.126 31.53 8.525 9.508
    Net Income 6.222 9.126 31.53 8.525 9.508
    Income Available to Common Excl. Extra. Items 6.222 9.126 31.53 8.525 9.508
    Income Available to Common Incl. Extra. Items 6.222 9.126 31.53 8.525 9.508
    Diluted Net Income 6.222 9.126 31.53 8.525 9.508
    Diluted Weighted Average Shares 39.8074 40.681 40.5257 39.7475 39.6777
    Diluted EPS Excluding Extraordinary Items 0.1563 0.22433 0.77802 0.21448 0.23963
    Diluted Normalized EPS 0.16232 0.23237 0.74068 0.22326 0.24097
    Research & Development 2.696 2.11 1.083 0.848 0
    Other Operating Expenses, Total -0.989 -1.622 -3.952 0.113 0.071
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 43.311 39.556 37.508 35.759 33.31
    Revenue 43.311 39.556 37.508 35.759 33.31
    Cost of Revenue, Total 17.205 15.552 14.612 14.108 12.92
    Gross Profit 26.106 24.004 22.896 21.651 20.39
    Total Operating Expense 40.41 37.622 33.974 34.29 32.309
    Selling/General/Admin. Expenses, Total 22.034 21.153 18.489 18.986 18.807
    Research & Development 0.758 0.78 0.722 0.67 0.672
    Depreciation / Amortization 0.298 0.24 0.241 0.291 0.243
    Unusual Expense (Income) 0.117 -0.022 0.178 0.292 -0.11
    Other Operating Expenses, Total -0.002 -0.081 -0.268 -0.057 -0.223
    Operating Income 2.901 1.934 3.534 1.469 1.001
    Interest Income (Expense), Net Non-Operating 0.157 0.084 0.05 0.042 0.387
    Net Income Before Taxes 3.058 2.018 3.584 1.511 1.388
    Net Income After Taxes 2.33 1.517 2.438 1.055 0.967
    Net Income Before Extra. Items 2.33 1.517 2.438 1.055 0.967
    Net Income 2.33 1.517 2.438 1.055 0.967
    Income Available to Common Excl. Extra. Items 2.33 1.517 2.438 1.055 0.967
    Income Available to Common Incl. Extra. Items 2.33 1.517 2.438 1.055 0.967
    Diluted Net Income 2.33 1.517 2.438 1.055 0.967
    Diluted Weighted Average Shares 40.6769 40.0167 39.6729 39.5834 39.7529
    Diluted EPS Excluding Extraordinary Items 0.05728 0.03791 0.06145 0.02665 0.02433
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS 0.05947 0.0375 0.0645 0.0318 0.0224
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 39.742 47.31 47.175 27.811 23.091
    Cash and Short Term Investments 16.914 28.408 30.981 13.355 10.413
    Cash & Equivalents 11.004 16.456 30.981 13.355 10.413
    Total Receivables, Net 15.405 14.716 12.373 11.534 8.839
    Accounts Receivable - Trade, Net 15.379 12.823 12.373 11.534 8.839
    Total Inventory 3.574 2.457 2.31 1.36 2.887
    Prepaid Expenses 3.849 1.729 1.511 1.562 0.952
    Total Assets 117.043 117.962 112.56 82.596 53.653
    Property/Plant/Equipment, Total - Net 68.437 62.846 55.056 54.772 30.562
    Property/Plant/Equipment, Total - Gross 108.336 90.901 75.345 68.452 39.384
    Accumulated Depreciation, Total -39.899 -28.055 -20.289 -13.68 -8.822
    Total Current Liabilities 18.861 17.811 23.017 25.912 19.571
    Accounts Payable 4.904 5.25 3.348 4.7 5.884
    Accrued Expenses 8.838 6.864 11.343 8.968 7.551
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.495 1.944 4.577 8.843 3.031
    Other Current Liabilities, Total 4.624 3.753 3.749 3.401 3.105
    Total Liabilities 19.949 23.142 30.867 38.897 21.082
    Total Long Term Debt 0.199 4.574 6.558 10.668 0.394
    Capital Lease Obligations 0.199 0.268 0.762 3.039 0.394
    Total Equity 97.094 94.82 81.693 43.699 32.571
    Common Stock 15.123 14.014 9.181 3.366 0.071
    Additional Paid-In Capital 12.125 7.749 7.32 6.377 5.39
    Retained Earnings (Accumulated Deficit) 69.846 73.335 65.643 34.113 27.11
    Total Liabilities & Shareholders’ Equity 117.043 117.962 112.56 82.596 53.653
    Total Common Shares Outstanding 38.0497 39.6404 39.1852 37.9527 37.5008
    Other Long Term Assets, Total 4.709 5.649 9.596 0.013 0
    Long Term Debt 0 4.306 5.796 7.629 0
    Other Liabilities, Total 0.889 0.757 1.292 2.317 1.117
    Other Equity, Total 0 -0.278 -0.451 -0.157 0
    Long Term Investments 4.155 2.157 0.733
    Cash 5.91 11.952
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total Current Assets 35.949 46.705 39.742 42.864 41.859
    Cash and Short Term Investments 10.224 23.544 16.914 21.478 21.922
    Cash & Equivalents 10.224 23.544 16.914 21.478 21.922
    Total Receivables, Net 18.922 16.32 15.405 15.073 14.818
    Accounts Receivable - Trade, Net 17.893 16.32 15.379 14.982 14.287
    Total Inventory 4.476 3.447 3.574 3.178 2.853
    Prepaid Expenses 2.327 3.394 3.849 3.135 2.266
    Total Assets 149.117 124.634 117.043 119.419 115.904
    Property/Plant/Equipment, Total - Net 73.938 68.438 68.437 68.109 66.685
    Property/Plant/Equipment, Total - Gross 118.908 111.249 108.336 104.587 100.175
    Accumulated Depreciation, Total -44.97 -42.811 -39.899 -36.478 -33.49
    Long Term Investments 4.052 4.051 4.155 2.22 2.435
    Other Long Term Assets, Total 4.731 5.44 4.709 6.226 4.925
    Total Current Liabilities 31.575 23.421 18.861 20.556 17.859
    Accounts Payable 8.902 6.66 4.904 6.406 5.887
    Accrued Expenses 11.793 10.419 8.838 9.12 6.675
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 3.544 0.397 0.495 0.385 0.895
    Other Current Liabilities, Total 7.336 5.945 4.624 4.645 4.402
    Total Liabilities 44.612 24.593 19.949 25.51 22.677
    Total Long Term Debt 12.257 0.162 0.199 4.392 4.433
    Long Term Debt 12.114 0 4.156 4.226
    Capital Lease Obligations 0.143 0.162 0.199 0.236 0.207
    Other Liabilities, Total 0.78 1.01 0.889 0.562 0.385
    Total Equity 104.505 100.041 97.094 93.909 93.227
    Common Stock 17.85 17.096 15.123 14.927 14.348
    Additional Paid-In Capital 13.488 12.087 12.125 10.808 9.991
    Retained Earnings (Accumulated Deficit) 73.167 70.858 69.846 68.118 68.944
    Other Equity, Total 0 0.056 -0.056
    Total Liabilities & Shareholders’ Equity 149.117 124.634 117.043 119.419 115.904
    Total Common Shares Outstanding 38.4004 38.2764 38.0497 38.1026 38.3331
    Goodwill, Net 29.759
    Intangibles, Net 0.688
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 6.222 9.126 31.53 8.525 9.508
    Cash From Operating Activities 27.748 22.494 35.11 19.087 22.368
    Cash From Operating Activities 15.63 11.312 9.582 6.4 3.783
    Non-Cash Items 14.285 11.733 12.932 13.694 9.156
    Changes in Working Capital -10.135 -13.561 -10.201 -10.257 -0.886
    Cash From Investing Activities -23.976 -19.746 -8.415 -12.811 -5.301
    Capital Expenditures -22.898 -19.743 -13.044 -13.385 -6.114
    Other Investing Cash Flow Items, Total -1.078 -0.003 4.629 0.574 0.813
    Cash From Financing Activities -15.266 -5.321 -9.069 -3.334 -11.752
    Issuance (Retirement) of Debt, Net -5.838 -3.999 -10.945 -2.208 -10.162
    Net Change in Cash -11.494 -2.573 17.626 2.942 5.315
    Deferred Taxes 1.746 3.884 -8.733 0.725 0.807
    Cash Taxes Paid -0.846 1.768 3.311 0.338 0.151
    Cash Interest Paid 0.231 0.351 0.559 0.333 0.193
    Issuance (Retirement) of Stock, Net -9.428 -1.322 1.876 -1.126 -1.59
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 1.517 6.222 3.784 2.729 1.762
    Cash From Operating Activities 10.496 27.748 20.064 12.092 7.146
    Cash From Operating Activities 4.762 15.63 11.257 7.136 3.397
    Deferred Taxes -0.725 1.746 0.745 0.745 0.745
    Non-Cash Items 5.604 14.285 10.524 7.177 3.216
    Cash Taxes Paid -0.04 -0.846 -0.92 -0.94 1.217
    Cash Interest Paid 0.042 0.231 0.185 0.128 0.066
    Changes in Working Capital -0.662 -10.135 -6.246 -5.695 -1.974
    Cash From Investing Activities -3.905 -23.976 -16.598 -10.495 -3.807
    Capital Expenditures -4.681 -22.898 -17.326 -10.989 -3.963
    Other Investing Cash Flow Items, Total 0.776 -1.078 0.728 0.494 0.156
    Cash From Financing Activities 0.039 -15.266 -10.396 -8.083 -2.499
    Issuance (Retirement) of Stock, Net 0.039 -9.428 -8.914 -7.12 -2.006
    Issuance (Retirement) of Debt, Net 0 -5.838 -1.482 -0.963 -0.493
    Net Change in Cash 6.63 -11.494 -6.93 -6.486 0.84
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Thrivent Asset Management, LLC Investment Advisor 9.1722 3511381 -1093827 2023-06-30 LOW
    Forager Capital Management, LLC Investment Advisor/Hedge Fund 5.055 1935191 -64455 2023-06-30 LOW
    Nantahala Capital Management, LLC Hedge Fund 4.515 1728495 135701 2023-06-30 MED
    Hillsdale Investment Management Inc. Investment Advisor/Hedge Fund 4.3036 1647541 121657 2023-06-30 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 3.9412 1508801 1291151 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.9906 1144875 180345 2023-06-30 LOW
    AWM Investment Company, Inc. Investment Advisor/Hedge Fund 2.8622 1095719 83693 2023-06-30 LOW
    Wasatch Global Investors Inc Investment Advisor/Hedge Fund 2.8416 1087845 -209634 2023-06-30 LOW
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 2.2143 847704 127413 2023-06-30 MED
    Cove Street Capital, LLC Investment Advisor 1.9427 743731 -141908 2023-06-30 LOW
    Triasima Portfolio Management Inc. Investment Advisor/Hedge Fund 1.9054 729428 136820 2023-06-30 HIGH
    Jarislowsky Fraser, Ltd. Investment Advisor 1.7402 666196 182153 2023-06-30 LOW
    Punch & Associates Investment Management, Inc. Investment Advisor/Hedge Fund 1.3324 510085 18270 2023-09-30 LOW
    Voce Capital Management, LLC Hedge Fund 1.3268 507941 -68897 2023-06-30 MED
    Connor, Clark & Lunn Investment Management Ltd. Investment Advisor/Hedge Fund 1.2165 465700 241800 2023-06-30 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.1377 435558 407531 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8952 342707 323278 2023-06-30 LOW
    Tocqueville Asset Management LP Investment Advisor/Hedge Fund 0.8489 325000 0 2023-06-30 LOW
    Raffles Capital Management, LLC Hedge Fund 0.8186 313378 -4040 2023-06-30
    BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.8156 312244 62665 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Viemed Healthcare Company profile

    About Viemed Healthcare Inc

    Viemed Healthcare, Inc. (Viemed) is a provider of in-home durable medical equipment (DME) and post-acute respiratory healthcare services in the United States. Viemed is focused on providing home therapy for patients suffering from respiratory diseases. Viemed's services include respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and respiratory equipment rentals. Its respiratory disease management provides treatment of chronic obstructive pulmonary disease (COPD) by using non-invasive ventilation (NIV) and other therapies. Its Neuromuscular care is focused on helping neuromuscular patients breathe comfortably by using respiratory therapy treatment. Its Oxygen therapy provides patients with extra oxygen suffering from chronic health problems, including COPD. It Sleep apnea management provides solutions and/or equipment such as the AutoPAP (automatic continuous positive airway pressure) and BiPAP machines.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Viemed Healthcare Inc revenues decreased 11% to $117.1M. Net income decreased 71% to $9.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Loss (gain) on disposal of property and increase from $2.3M (income) to $448K (expense), Other expense (income) decrease of 59% to $1.6M (income), Selling.

    Industry: Healthcare Facilities & Services (NEC)

    625 E. Kaliste Saloom Rd.
    LAFAYETTE
    LOUISIANA 70508
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Gold

    2,004.85 Price
    -1.180% 1D Chg, %
    Long position overnight fee -0.0198%
    Short position overnight fee 0.0116%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    Oil - Crude

    71.41 Price
    +2.320% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    BTC/USD

    44,039.40 Price
    -1.250% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    US100

    16,080.90 Price
    +0.500% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading